✦ LIBER ✦

Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: A case series in Taiwan

✍ Scribed by Yung-Tsu CHO; Chien-Hung CHEN; Hsien-Yi CHIU; Tsen-Fang TSAI

Book ID: 114702864
Publisher: John Wiley and Sons
Year: 2011
Tongue: French
Weight: 146 KB
Volume: 39
Category: Article
ISSN: 0385-2407
DOI: 10.1111/j.1346-8138.2011.01434.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of antitumour necrosis factor-α t

Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection

✍ L. Nosotti; F. Francesconi; S. Izzi; E. Berardesca; A. Morrone; C. Bonifati 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Safety of tumor necrosis factor α blocke

Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti–hepatitis B core antigen positive) with rheumatic diseases

✍ R. Caporali; F. Bobbio-Pallavicini; F. Atzeni; G. Sakellariou; M. Caprioli; C. M 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 84 KB 👁 1 views

PAR25 ASSOCIATION OF PERSISTENCE WITH AN

PAR25 ASSOCIATION OF PERSISTENCE WITH ANTI-TUMOR NECROSIS FACTOR (ANTI-TNF) THERAPY AND HEALTH CARE COSTS IN PATIENTS WITH PSORIATIC ARTHRITIS

✍ B Tang; MI Rahman; B Meissner; O Dabbous; A Naim; HC Thompson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Use of tumor necrosis factor-α (TNF-α) a

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

✍ Sophia Li; Primal P. Kaur; Virginia Chan; Steven Berney 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 102 KB

Single-center series and systematic revi

Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?

✍ Nannini, Carlotta ;Cantini, Fabrizio ;Niccoli, Laura ;CassarÀ, Emanuele ;Salvara 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

A comparison of response criteria to eva

A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti–tumor necrosis factor α agents

✍ A. Lurati; I. Pontikaki; B. Teruzzi; F. Desiati; V. Gerloni; M. Gattinara; R. Ci 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views